Merck price target raised to $150 from $135 at HSBC
HSBC analyst Rajesh Kumar raised the firm's price target on Merck to $150 from $135 and keeps a Buy rating on the shares. In a sector note on Healthcare, HSBC adjusted target prices on the prospects of the sector's relative outperformance potential for the second half of the year, noting that the Therapeutics space off